ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

October 8, 2004

Mammography Controversy Continues: Task Force Alters Web Site To Clarify Recommendation On Mammography

December 4, 2009

Cancer Program Depend On Vitality Of Centers, Broder ells DCPC Board

May 12, 1989

In Brief: Congress Working On Interim Financing Measure to Fund Agencies, Including NCI, Through Election

September 26, 1980

Mammography: Panel Member Quits Over “One-Sided” Document

February 14, 1997

Vaccine Prevented Cervical Pre-Cancers, Non-Invasive Cancers In Phase III Trial

October 28, 2005